These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34327580)

  • 1. MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.
    Jayaprakasam VS; Paroder V; Gibbs P; Bajwa R; Gangai N; Sosa RE; Petkovska I; Golia Pernicka JS; Fuqua JL; Bates DDB; Weiser MR; Cercek A; Gollub MJ
    Eur Radiol; 2022 Feb; 32(2):971-980. PubMed ID: 34327580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
    Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
    Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of locally advanced rectal cancer response to neoadjuvant chemoradiation therapy using volumetric multiparametric MRI-based radiomics.
    El Homsi M; Bane O; Fauveau V; Hectors S; Vietti Violi N; Sylla P; Ko HB; Cuevas J; Carbonell G; Nehlsen A; Vanguri R; Viswanath S; Jambawalikar S; Shaish H; Taouli B
    Abdom Radiol (NY); 2024 Mar; 49(3):791-800. PubMed ID: 38150143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
    Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
    Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
    Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
    Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
    Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
    [No Abstract]   [Full Text] [Related]  

  • 8. MRI radiomics signature to predict lymph node metastasis after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Fang Z; Pu H; Chen XL; Yuan Y; Zhang F; Li H
    Abdom Radiol (NY); 2023 Jul; 48(7):2270-2283. PubMed ID: 37085730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic prediction value of the clinical-radiomics tumour-stroma ratio in locally advanced rectal cancer.
    Cai C; Hu T; Rong Z; Gong J; Tong T
    Eur J Radiol; 2024 Jan; 170():111254. PubMed ID: 38091662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy.
    Petkovska I; Tixier F; Ortiz EJ; Golia Pernicka JS; Paroder V; Bates DD; Horvat N; Fuqua J; Schilsky J; Gollub MJ; Garcia-Aguilar J; Veeraraghavan H
    Abdom Radiol (NY); 2020 Nov; 45(11):3608-3617. PubMed ID: 32296896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.
    Park H; Kim KA; Jung JH; Rhie J; Choi SY
    Eur Radiol; 2020 Aug; 30(8):4201-4211. PubMed ID: 32270317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment MRI-Based Radiomics for Prediction of Rectal Cancer Outcome: A Discovery and Validation Study.
    Huang H; Han L; Guo J; Zhang Y; Lin S; Chen S; Lin X; Cheng C; Guo Z; Qiu Y
    Acad Radiol; 2024 May; 31(5):1878-1888. PubMed ID: 37996362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
    Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
    Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomic Features of Primary Rectal Cancers on Baseline T
    Antunes JT; Ofshteyn A; Bera K; Wang EY; Brady JT; Willis JE; Friedman KA; Marderstein EL; Kalady MF; Stein SL; Purysko AS; Paspulati R; Gollamudi J; Madabhushi A; Viswanath SE
    J Magn Reson Imaging; 2020 Nov; 52(5):1531-1541. PubMed ID: 32216127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
    Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy.
    Çelik H; Barlık F; Sökmen S; Terzi C; Canda AE; Sağol Ö; Sarıoğlu S; Ünlü M; Bilkay Görken İ; Arıcan Alıcıkuş Z; Öztop İ
    Diagn Interv Radiol; 2023 Mar; 29(2):219-227. PubMed ID: 36971272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.
    Lee YD; Kim HG; Seo M; Moon SK; Park SJ; You MW
    Int J Colorectal Dis; 2024 May; 39(1):78. PubMed ID: 38789861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
    Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based radiomics to predict response in locally advanced rectal cancer: comparison of manual and automatic segmentation on external validation in a multicentre study.
    Defeudis A; Mazzetti S; Panic J; Micilotta M; Vassallo L; Giannetto G; Gatti M; Faletti R; Cirillo S; Regge D; Giannini V
    Eur Radiol Exp; 2022 May; 6(1):19. PubMed ID: 35501512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.